Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Queensland Health
Covington
Argus Health
Julphar
Citi
Johnson and Johnson
UBS

Generated: June 19, 2018

DrugPatentWatch Database Preview

Taro Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARM INDS, and when can generic versions of TARO PHARM INDS drugs launch?

TARO PHARM INDS has thirty-one approved drugs.

There are two US patents protecting TARO PHARM INDS drugs. There is one tentative approval on TARO PHARM INDS drugs.

There are ten patent family members on TARO PHARM INDS drugs in seven countries and nineteen supplementary protection certificates in nine countries.

Summary for Taro Pharm Inds
International Patents:10
US Patents:2
Tradenames:21
Ingredients:19
NDAs:31

Drugs and US Patents for Taro Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds ETODOLAC etodolac TABLET;ORAL 075074-002 Apr 25, 2000 AB RX No Yes ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd HYDROCORTISONE AND ACETIC ACID acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 088759-001 Mar 4, 1985 AT RX No No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd INFANTS' FEVERALL acetaminophen SUPPOSITORY;RECTAL 018337-004 Aug 26, 1992 OTC Yes No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 040039-001 Nov 26, 1997 AT RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for TARO PHARM INDS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18

Non-Orange Book US Patents for Taro Pharm Inds

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,039,657 Process for preparing malathion for pharmaceutical use ➤ Sign Up
8,957,238 Process for preparing malathion for pharmaceutical use ➤ Sign Up
8,536,155 Process for preparing malathion for pharmaceutical use ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Taro Pharm Inds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
13/044 Ireland ➤ Sign Up PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
C/GB11/054 United Kingdom ➤ Sign Up PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C/GB08/026 United Kingdom ➤ Sign Up PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080111; UK EU/1/07/434/002 20080111; UK EU/1/07/434/003 20080111
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
QuintilesIMS
Colorcon
Medtronic
Healthtrust
Baxter
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.